Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial

IMPORTANCE: Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment of high-risk outpatients with COVID-19 in developing countries are needed. OBJECTIVE: To determine whether hydroxychloroquine or lopinavir-ritonavir reduces hospitalization among high-risk patients with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Gilmar, Moreira Silva, Eduardo Augusto dos Santos, Medeiros Silva, Daniela Carla, Thabane, Lehana, Singh, Gurmit, Park, Jay J. H., Forrest, Jamie I., Harari, Ofir, Quirino dos Santos, Castilho Vitor, Guimarães de Almeida, Ana Paula Figueiredo, de Figueiredo Neto, Adhemar Dias, Savassi, Leonardo Cançado Monteiro, Milagres, Aline Cruz, Teixeira, Mauro Martins, Simplicio, Maria Izabel Campos, Ribeiro, Luciene Barra, Oliveira, Rosemary, Mills, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063069/
https://www.ncbi.nlm.nih.gov/pubmed/33885775
http://dx.doi.org/10.1001/jamanetworkopen.2021.6468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063069/
https://www.ncbi.nlm.nih.gov/pubmed/33885775
http://dx.doi.org/10.1001/jamanetworkopen.2021.6468

Ejemplares similares